, a director of external affairs for AT&T and a South Pasadena resident, has served as president of the Pasadena chamber and is involved in various business, community and charitable organizations throughout the Burbank, Glendale and Pasadena area.
is a valued partner to over 50 companies worldwide.
It's a formulated revenue share based on a blended value of all commodities," says Roche
With the merger, Roche
hopes to establish a strong development and sales base for new products in Japan, while Chugai is eyeing engaging in global research and development operations.
spent her last few weeks on the job choreographing her own farewell party--a gala performance of The Sleeping Beauty.
6 percent, and Roche
has reduced its overall costs by 50 percent.
Without the Roche
deal, Raab insists, Genentech would have been forced to cut back on R&D and scuttle viable projects.
Thousand Oaks-based Amgen is seeking a permanent injunction blocking this Roche
foray into the domestic marketplace.
has a proven successful track record in developing biologicals as innovative new products.
With a portfolio of over one thousand products, Roche
Custom Biotech also custom manufactures to customer needs.
It builds on the recent agreement announced by Roche
with the Institut Pasteur, which should enable Roche
to develop an extensive range of diagnostic products for the early detection of HPV, one of the most prevalent and serious sexually transmitted diseases in the world.
But I don't think Amgen's deal with Roche
will have any influence on Amgen's acquisition of Immunex,'' said Stefan Loren, analyst with Legg Mason in Baltimore.